Now Available: Spotlight on Alamar Biosciences CEO Yuling Luo. Click here to read.
SonoThera™, a biotechnology company dedicated to treating the root cause of human diseases through genetic therapy, announced completion of its $60.75M Series A financing round.
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced it has raised $80 million in a Series B financing. The round was led by Novalis LifeSciences and included new investors Illumina Ventures, Albany Capital and Catalio Capital Management, among others. They joined Northpond Ventures, Good Ventures, and other existing inve...
Kallyope, Inc., a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis, today announced the closing of a $236 million Series D financing co-led by Mubadala Investment Company and The Column Group, along with participation from other new and existing investors (including Illumina Ventures). The funds will be used to advance the company’s ...
Biotech firm Protillion Biosciences has closed an $18 million Series A financing round funded by Arch Venture Partners and Illumina Ventures.
Your screen does not meet the requirements for generating previews. Adjust your screen width to exactly 1920px before proceeding, otherwise you'll not be able to generate previews.
